Carmell Therapeutics Stock Technical Analysis
| CTCXW Stock | 0.06 0 1.96% |
As of the 29th of November, Carmell Therapeutics shows the Downside Deviation of 18.09, risk adjusted performance of 0.0129, and Mean Deviation of 12.44. Carmell Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Carmell Therapeutics standard deviation, value at risk, as well as the relationship between the Value At Risk and kurtosis to decide if Carmell Therapeutics is priced correctly, providing market reflects its regular price of 0.06 per share. As Carmell Therapeutics appears to be a penny stock we also recommend to validate its total risk alpha numbers.
Carmell Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Carmell, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to CarmellCarmell |
Carmell Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Carmell Therapeutics Technical Analysis
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.
Carmell Therapeutics Trend Analysis
Use this graph to draw trend lines for Carmell Therapeutics. You can use it to identify possible trend reversals for Carmell Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Carmell Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Carmell Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Carmell Therapeutics applied against its price change over selected period. The best fit line has a slop of 0.0013 , which may suggest that Carmell Therapeutics market price will keep on failing further. It has 122 observation points and a regression sum of squares at 0.07, which is the sum of squared deviations for the predicted Carmell Therapeutics price change compared to its average price change.About Carmell Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Carmell Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Carmell Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Carmell Therapeutics price pattern first instead of the macroeconomic environment surrounding Carmell Therapeutics. By analyzing Carmell Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Carmell Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Carmell Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
Carmell Therapeutics November 29, 2024 Technical Indicators
Most technical analysis of Carmell help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Carmell from various momentum indicators to cycle indicators. When you analyze Carmell charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0129 | |||
| Market Risk Adjusted Performance | 0.0469 | |||
| Mean Deviation | 12.44 | |||
| Semi Deviation | 14.23 | |||
| Downside Deviation | 18.09 | |||
| Coefficient Of Variation | 22898.95 | |||
| Standard Deviation | 19.17 | |||
| Variance | 367.6 | |||
| Information Ratio | (0) | |||
| Jensen Alpha | (0.16) | |||
| Total Risk Alpha | (2.81) | |||
| Sortino Ratio | (0) | |||
| Treynor Ratio | 0.0369 | |||
| Maximum Drawdown | 87.8 | |||
| Value At Risk | (27.31) | |||
| Potential Upside | 33.56 | |||
| Downside Variance | 327.41 | |||
| Semi Variance | 202.59 | |||
| Expected Short fall | (17.94) | |||
| Skewness | 1.3 | |||
| Kurtosis | 3.22 |
Additional Tools for Carmell Stock Analysis
When running Carmell Therapeutics' price analysis, check to measure Carmell Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Carmell Therapeutics is operating at the current time. Most of Carmell Therapeutics' value examination focuses on studying past and present price action to predict the probability of Carmell Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Carmell Therapeutics' price. Additionally, you may evaluate how the addition of Carmell Therapeutics to your portfolios can decrease your overall portfolio volatility.